flow trial semaglutide kidney outcomes 2024 nejm hazard ratio 0.76 FLOW- the Visual Abstract — NephJC Effects of semaglutide with and – Effects of Semaglutide With or

The CREDENCE clinical trial evaluated the effects of canagliflozin 100 mg daily versus placebo in 4401 patients with T2DM and chronic kidney disease (CKD)

Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants

Substrate strands (sequences in Supplementary Dataset 1) contained 5 nucleotides of mismatched sequence, allowing differentiation of the two independent strands in each repaired substrate molecule, either by strand-specific fluorescent probes or by next-generation sequencing (see below)

Western blotting was performed based on regular procedures